Sequans Communications SA
Change company Symbol lookup
Select an option...
SQNS Sequans Communications SA
WSTL Westell Technologies Inc
TSLA Tesla Inc
TWLO Twilio Inc
JHS John Hancock Income Securities Trust
AMRC Ameresco Inc
ET Energy Transfer LP
AHCO Adapthealth Corp
LPSN LivePerson Inc
BGSF BGSF Inc
Go

Information Technology : Semiconductors & Semiconductor Equipment |
Based in France
Company profile

Sequans Communications SA is a France-based company that develops and provides 5G and 4G chips and modules for massive, broadband, and IoT (Internet of things). The Company provides a product portfolio for 5G/4G massive IoT applications based on Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, featuring low power consumption, a set of integrated functionalities, and global deployment capability. The Company offers a product portfolio for 5G/4G broadband and critical IoT applications based on its Cassiopeia Cat 4/Cat 6 4G and high-end Taurus 5G chip platforms, optimized for low-cost residential, enterprise, and industrial applications. The Company is based in Paris, France and operates as well in the United States, United Kingdom, and Asia in countries such as Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$4.99
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
94,207
0

AbbVie Inc. Stock Outperforms Market On Strong Trading Day

4:33 pm ET October 22, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) inched 0.35% higher to $109.14 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.21% to 35,677.02 and the S&P 500 Index falling 0.11% to 4,544.90. This was the stock's fourth consecutive day of gains. AbbVie Inc. closed $12.39 below its 52-week high ($121.53), which the company achieved on September 1st.

The stock underperformed when compared to some of its competitors Friday, as Pfizer Inc. (PFE) rose 0.70% to $43.16, Eli Lilly & Co. (LLY) rose 1.07% to $243.75, and AstraZeneca PLC ADR (AZN.LN) rose 0.93% to $61.79. Trading volume (4.6 M) remained 2.9 million below its 50-day average volume of 7.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 22, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

October 22, 2021 16:33 ET (20:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.